FP7H2020HORIZON
Istituto Giannina Gaslini
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 21
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 6,432,933
- Active
- 2008 to 2025
Projects
21 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| PanCare4AYAPatient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer | HORIZON | 2025 | Participant | Not stated |
| MONALISAA SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis | HORIZON | 2024 | Participant | EUR 84,800 |
| TRELTwinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania | H2020 | 2021 | Participant | EUR 45,556 |
| PanCareFollowUpPanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers | H2020 | 2019 | Participant | EUR 451,000 |
| TAT-CFNovel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters | H2020 | 2016 | Participant | EUR 390,003 |
| MD PAEDIGREEModel-Driven European Paediatric Digital Repository | FP7 | 2013 | Participant | EUR 307,960 |
| PANCARELIFEPanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood | FP7 | 2013 | Participant | EUR 199,989 |
| GAPPGAbapentin in Paediatric Pain | FP7 | 2013 | Participant | EUR 85,562 |
| DESIREDevelopment and Epilepsy - Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy | FP7 | 2013 | Participant | EUR 192,372 |
| EUTRAINEUropean TRanslational training for Autoimmunity & Immune manipulation Network | FP7 | 2012 | Participant | EUR 504,973 |
| PREVENTROPNew approach to treatment of the blinding disease Retinopathy of Prematurity (ROP) | FP7 | 2012 | Participant | EUR 421,454 |
| ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk | FP7 | 2012 | Participant | EUR 422,175 |
| EPIPGXEpilepsy Pharmacogenomics: delivering biomarkers for clinical use | FP7 | 2011 | Participant | EUR 252,864 |
| PANCARESURFUPPanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies | FP7 | 2011 | Participant | EUR 250,780 |
| PHARMACHILDLong-term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulatory drugs | FP7 | 2011 | Participant | EUR 1,241,550 |
| ENCCAEUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS | FP7 | 2011 | Participant | EUR 438,014 |
| LEUKOTREATTherapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials | FP7 | 2010 | Participant | EUR 100,300 |
| INFLA-CAREUnderstanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies | FP7 | 2009 | Participant | EUR 512,000 |
| EUROTRAPSNatural course, pathophysiology, models for early diagnosis, prevention and innovative treatment of TNF Receptor Associated Periodic Syndrome TRAPS with application for all hereditary recurrent fevers | FP7 | 2008 | Participant | EUR 334,162 |
| INNATE_CROSSTALKInnate immunity crosstalk in immunoregulation | FP7 | 2008 | Coordinator | EUR 86,869 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.